CD68 and neoplasm: To analyze the characteristics of the TIME in different tumor regions, we first detected the expression of immune markers including CD4+, CD8+, Foxp3+, CD20+, CD68+, LAMP3+, PD-1+ TILs, and PD-L1 in different tumor regions using IHC.